Schöffski O - Search Results

1

Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease.

Merkesdal S, Ruof J, Schöffski O, Bernitt K, Zeidler H, Mau W. Merkesdal S, et al. Among authors: schoffski o. Arthritis Rheum. 2001 Mar;44(3):528-34. doi: 10.1002/1529-0131(200103)44:3<528::AID-ANR100>3.0.CO;2-U. Arthritis Rheum. 2001. PMID: 11263766 Free article.

2

[Cost-effectiveness--limits between optimization and rationing].

Ruof J, Schöffski O. Ruof J, et al. Among authors: schoffski o. Z Rheumatol. 1998 Oct;57(5):340-4. doi: 10.1007/s003930050126. Z Rheumatol. 1998. PMID: 9864843 German.

3

[Instruments for Measuring the Effects of Early Intervention on Maintaining and Restoring Ability to Work in Germany: Opinion of an Interdisciplinary Working Group].

Amler N, Felder S, Mau W, Merkesdal S, Schöffski O; und Mitglieder des Arbeitsgruppe. Amler N, et al. Among authors: schoffski o. Gesundheitswesen. 2018 Jan;80(1):79-86. doi: 10.1055/s-0041-110678. Epub 2015 Dec 22. Gesundheitswesen. 2018. PMID: 26695541 German.

4

Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.

Schöffski O, Augustin M, Prinz J, Rauner K, Schubert E, Sohn S, Reich K. Schöffski O, et al. J Dtsch Dermatol Ges. 2007 Mar;5(3):209-18. doi: 10.1111/j.1610-0387.2007.06240.x. J Dtsch Dermatol Ges. 2007. PMID: 17338796 English, German.

5

Consequences of implementing a drug budget for office-based physicians in Germany.

Schöffski O. Schöffski O. Pharmacoeconomics. 1996;10 Suppl 2:37-47. doi: 10.2165/00019053-199600102-00007. Pharmacoeconomics. 1996. PMID: 10163434 Review.

6

[Economic evaluation in oncology].

Schöffski O. Schöffski O. Med Klin (Munich). 2000 Jun;95 Suppl 1:14-7. Med Klin (Munich). 2000. PMID: 10941248 Review. German.

7

Resource utilization and costs of stroke unit care in Germany.

Dodel RC, Haacke C, Zamzow K, Paweilik S, Spottke A, Rethfeldt M, Siebert U, Oertel WH, Schöffski O, Back T. Dodel RC, et al. Among authors: schoffski o. Value Health. 2004 Mar-Apr;7(2):144-52. doi: 10.1111/j.1524-4733.2004.72314.x. Value Health. 2004. PMID: 15164804 Free article.

8

Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project.

Kolominsky-Rabas PL, Heuschmann PU, Marschall D, Emmert M, Baltzer N, Neundörfer B, Schöffski O, Krobot KJ. Kolominsky-Rabas PL, et al. Among authors: schoffski o. Stroke. 2006 May;37(5):1179-83. doi: 10.1161/01.STR.0000217450.21310.90. Epub 2006 Mar 30. Stroke. 2006. PMID: 16574918

9

Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.

Schöffski O, Breitscheidel L, Benter U, Dippel FW, Müller M, Volk M, Pfohl M. Schöffski O, et al. J Med Econ. 2008;11(4):695-712. doi: 10.3111/13696990802645726. J Med Econ. 2008. PMID: 19450076 Free article.

10

Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper.

Breitscheidel L, Stamenitis S, Dippel FW, Schöffski O. Breitscheidel L, et al. Among authors: schoffski o. J Med Econ. 2010 Mar;13(1):8-15. doi: 10.3111/13696990903479199. J Med Econ. 2010. PMID: 19947905 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters